The presence of a transmembrane protease serine 2:v-ets erythroblastosis virus E26 oncogene homolog (TMPRSS2-ERG) fusion is diagnostic of prostate carcinoma [55], and many fusions are diagnostic of various sarcomas [56,57]. This evidence concerns the gene ERG and prostate carcinoma.